1. Introduction to Medpace Holdings Inc.
Medpace Holdings Inc., headquartered in Cincinnati, Ohio, is a globally recognized clinical research organization (CRO) that provides comprehensive, full-service drug development services to the biopharmaceutical industry. Founded in 1992, Medpace has grown into a leader in the healthcare sector, employing over 5,000 professionals across more than 40 countries. The company’s reputation is built on its scientific rigor, operational excellence, and commitment to accelerating the approval of new therapies. Medpace specializes in all phases of clinical trials, from early-phase development to post-marketing surveillance, serving small to large pharmaceutical companies, biotech firms, and academic institutions. With a strong focus on therapeutic areas such as oncology, cardiology, metabolic diseases, and central nervous system disorders, Medpace is recognized as a top CRO by industry analysts and clients alike. The company’s integrated approach combines clinical operations, data management, biostatistics, regulatory affairs, and safety surveillance, ensuring seamless trial execution. Medpace’s market reputation is further enhanced by its adherence to Good Clinical Practice (GCP) guidelines, innovative technology platforms, and a dedicated team of scientific experts. Organizations choose Medpace because of its ability to deliver high-quality results, maintain robust patient safety standards, and reduce time-to-market for new drugs. In a competitive landscape, Medpace stands out for its scientific expertise, customer-centric culture, and consistent performance in clinical trials. As part of the Medpace Holdings Inc. company profile, this listing highlights the commitment to advancing global health through rigorous research and ethical practices.
2. Company History and Business Evolution
Medpace Holdings Inc. was founded in 1992 by Dr. August J. Troendle, a physician and epidemiologist, with a vision to create a CRO that prioritized scientific integrity and clinical excellence. The early years were marked by a focus on small molecule and vaccine trials, gradually expanding into complex therapeutic areas. In 2002, Medpace established its first European office, signaling its entry into the global market. A key milestone came in 2016 with the company’s initial public offering (IPO) on the NASDAQ (MEDP), which provided capital for further expansion. Over the next decade, Medpace made strategic acquisitions, including the purchase of a biostatistics firm and a medical imaging company, to enhance its service offerings. The company also invested heavily in technology, developing proprietary platforms like Medpace for Clinical Operations (MCO) and Medpace Risk-Based Monitoring (RBM). In 2020, Medpace opened a state-of-the-art headquarters in Cincinnati, consolidating its operations. More recently, Medpace has expanded its presence in Asia-Pacific and Latin America, tapping into emerging markets for clinical trials. The evolution of Medpace is characterized by a shift from a mid-sized CRO to a top-tier global player, known for its therapeutic expertise and high retention rates. Innovations such as decentralized trial capabilities and real-world evidence integration have kept Medpace at the forefront of the industry. Today, Medpace continues to grow organically and through partnerships, aiming to further its mission of bringing life-saving therapies to patients worldwide.
3. Medpace Holdings Inc. at a Glance
- Headquarters: Cincinnati, Ohio, USA
- Founded: 1992
- Founder & CEO: Dr. August J. Troendle
- Revenue: $1.87 billion (2023)
- Employees: Over 5,000 globally
- Stock Symbol: NASDAQ: MEDP
- Industry: Clinical Research Organization (CRO) / Healthcare
- Therapeutic Focus: Oncology, Cardiology, CNS, Metabolic, Vaccines, Rare Diseases
- Global Presence: 40+ countries
- Certifications: ISO 9001, ISO 27001, GCP Compliance
- Awards: Best CRO (multiple years by various publications)
- Key Services: Phase I-IV Clinical Trials, Data Management, Biostatistics, Regulatory Affairs, Medical Writing, Safety Surveillance, Medical Imaging, Central Lab
- Technology Platforms: Medpace for Clinical Operations (MCO), Risk-Based Monitoring, Real-World Evidence
- Patient Reach: Over 500,000 patients enrolled in trials
- Partnerships: Major pharma, biotech, and academic institutions
- Diversity & Inclusion: Active initiatives for workforce diversity
- Sustainability: Environmental goals to reduce carbon footprint
- Notable Milestones: IPO in 2016, Expansion into Asia-Pacific in 2021
- Key Leaders: Dr. August J. Troendle (CEO), Dr. Julia A. Davis (COO), Mr. John F. Kling (CFO)
- Client Retention Rate: over 90%
4. Mission, Vision, and Core Corporate Values
Medpace Holdings Inc.’s mission is to accelerate the development of new therapies by providing scientific and operational expertise to biopharmaceutical companies. The vision is to be the most trusted CRO globally, known for integrity, quality, and patient-centricity. Core values include: Scientific Excellence – ensuring every trial is designed and executed with rigorous scientific standards; Integrity – maintaining transparency and ethical conduct in all interactions; Collaboration – fostering teamwork across functions and with clients; Innovation – embracing technology and novel approaches to improve efficiency; Patient Focus – putting patient safety and well-being at the center of every trial. These values guide decision-making and culture at Medpace, creating an environment where employees feel empowered to contribute to life-changing research.
5. Business Strategy and Future Roadmap
Medpace’s business strategy centers on organic growth, therapeutic specialization, and technological innovation. The company plans to expand its footprint in high-growth therapeutic areas such as cell and gene therapy, while also increasing its presence in Asia-Pacific and Latin America. Key initiatives include enhancing decentralized trial capabilities, investing in artificial intelligence for data analytics, and strengthening real-world evidence services. Medpace aims to deepen relationships with existing clients through exceptional performance and cross-selling. The roadmap includes strategic acquisitions to fill service gaps, such as medical imaging or central laboratory services. Additionally, Medpace is committed to sustainability, targeting carbon neutrality by 2030. The future also involves leveraging its proprietary platforms to offer faster, more cost-effective trials. By 2028, Medpace expects to double its revenue through these initiatives while maintaining high client satisfaction.
6. Products, Technologies, and Services
Medpace offers a full suite of clinical development services, including:
- Clinical Trial Management: Full-service management from protocol design to close-out.
- Data Management & Biostatistics: Collection, cleaning, and analysis of trial data using advanced statistical methods.
- Regulatory Affairs: Submission support for FDA, EMA, and other regulatory bodies.
- Safety Surveillance: Pharmacovigilance and medical monitoring services.
- Medical Writing: Preparation of clinical study reports, investigator brochures, and regulatory documents.
- Medical Imaging: Core lab services for imaging endpoints.
- Central Laboratory: Sample analysis and storage.
- Technology Platforms: Medpace for Clinical Operations (MCO) – an integrated trial management system; Risk-Based Monitoring (RBM) – leveraging data to focus on high-risk sites; Real-World Evidence (RWE) – using real-world data to complement clinical trials.
7. Industries and Markets Served
Medpace serves the pharmaceutical, biotechnology, medical device, and academic research industries. Its clients range from top-20 global pharma companies to emerging biotech firms with a single product. Medpace has expertise in over 25 therapeutic areas, with particular strengths in oncology (covers 40% of trials), cardiology, metabolic diseases (diabetes, NASH), central nervous system (Alzheimer’s, Parkinson’s), infectious diseases, and rare diseases. The company also supports generic and biosimilar development. Medpace’s markets include North America (60% of revenue), Europe (25%), and Rest of World (15%). The company is expanding into Asia-Pacific, especially China and India, due to the growing number of clinical trials in those regions.
8. Leadership and Management Philosophy
Medpace’s leadership team, led by founder Dr. August J. Troendle, emphasizes a science-first approach. Dr. Troendle, a physician and epidemiologist, instills a culture of clinical excellence and ethical conduct. The management philosophy is built on employee empowerment, transparent communication, and accountability. Leaders are expected to mentor junior staff and foster an inclusive environment. Medpace holds regular town halls where executives share strategic updates. The company encourages innovation through cross-functional collaboration and rewards employees for contributing to process improvements. Leadership also prioritizes work-life balance and professional development, with an average tenure of 5+ years among managers.
9. Corporate Events, Conferences, and Community Engagement
Medpace actively participates in industry conferences such as DIA, SCOPE, and the American Society of Clinical Oncology (ASCO) annual meeting. The company hosts its own Symposia on topics like decentralized trials and regulatory trends. Community engagement includes volunteer programs for health screenings and supporting local non-profits in Cincinnati. Medpace also runs an internship program for students in clinical research and life sciences. Annually, Medpace’s charitable arm, Medpace Cares, supports health-related causes through employee donations and corporate matching. These events strengthen Medpace’s brand and attract talent who value corporate social responsibility.
10. Employees and Workplace Culture
Medpace employs over 5,000 people worldwide, with a strong focus on employee development. The company offers competitive compensation, benefits, and opportunities for advancement. Culture is described as collaborative, fast-paced, and mission-driven. Employees report high levels of job satisfaction due to the meaningful nature of their work in bringing new therapies to patients. Medpace supports diversity through employee resource groups (ERGs) for women, minorities, and LGBTQ+. The company also provides reimbursement for continuing education (e.g., certifications in clinical research). Work environment emphasizes integrity, with regular ethics training. Flexible work arrangements, including hybrid options, are available for many roles.
11. Job Details & Requirements for this Posting
Job Title: Clinical Research Associate (CRA)
Location: Cincinnati, OH (hybrid) or remote for experienced candidates.
Job Type: Full-time
Salary Range: $70,000 – $100,000 annually, plus bonus and benefits.
Responsibilities:
- Conduct site qualification, initiation, monitoring, and close-out visits for clinical trials.
- Ensure investigator sites comply with protocol, GCP, and regulatory requirements.
- Review case report forms (CRFs) and source documents for accuracy and completeness.
- Communicate with site staff, sponsors, and internal Medpace teams.
- Resolve data queries and escalate issues as needed.
- Prepare monitoring reports and follow-up letters.
- Assist with site selection and feasibility assessments.
Qualifications:
- Bachelor’s degree in life sciences (e.g., biology, nursing, pharmacy) or equivalent.
- Minimum 2 years of on-site monitoring experience in pharmaceutical or CRO setting.
- Thorough knowledge of ICH-GCP guidelines and FDA regulations.
- Strong communication, organizational, and problem-solving skills.
- Ability to travel up to 60% of the time.
- Certification as a Clinical Research Associate (CCRA) preferred.
Why Join Medpace Holdings Inc.?
Medpace offers a supportive environment where you can grow your career while contributing to life-saving research. Benefits include health insurance, 401(k) matching, paid time off, tuition reimbursement, and stock purchase plans. You will work with world-class scientists and have access to cutting-edge tools. Medpace’s high retention rate reflects employee satisfaction. Moreover, as a top CRO, Medpace provides exposure to diverse therapeutic areas and global trials. Joining Medpace means being part of a team that values your expertise and invests in your development.
12. Customer Reviews and Industry Reputation
The following section provides an exhaustive overview of Medpace’s reputation based on reviews from employees, clients, and industry analysts. To ensure comprehensiveness, we cover multiple platforms.
GLASSDOOR
On Glassdoor, Medpace Holdings Inc. has a 4.1 out of 5 rating based on over 1,000 reviews. Employees praise the company for its scientific culture, supportive management, and meaningful work. Common positives include “great work environment,” “opportunities to learn,” and “impactful projects.” Some negative reviews mention high workload during peak periods and occasional bureaucracy. Overall, 74% of employees would recommend Medpace to a friend, and 82% approve of the CEO. Many reviews highlight the collaborative atmosphere and emphasis on professional growth.
INDEED
Indeed reviews show a 4.0 rating with similar feedback. Employees appreciate the comprehensive training programs and competitive pay. Site mentions of “good benefits package” and “smart colleagues” are frequent. Negative aspects include limited career progression for some roles and the need for better work-life balance in certain departments. Nonetheless, Medpace consistently ranks as one of the top CROs to work for in employee surveys.
GARTNER PEER INSIGHTS
Gartner Peer Insights (now part of Gartner) has limited reviews for CROs, but Medpace scores highly among IT procurers for its technology platforms. Clients note the reliability of Medpace’s data management systems and responsive support. Average rating is 4.5/5, with recommendations for smaller biotechs due to personalized service.
TRUSTPILOT
Trustpilot reviews for Medpace are scarce because the platform primarily serves consumer-facing companies. However, client testimonials on Medpace’s website indicate high satisfaction: over 90% of clients rate the partnership as excellent, citing timely delivery and quality data.
G2
On G2, Medpace’s Clinical Operations platform (MCO) receives a 4.3 rating for ease of use and features. Users appreciate the integration with electronic data capture (EDC) systems. Some suggest enhancements in mobile functionality.
GOOGLE REVIEWS
Medpace’s corporate headquarters on Google Maps has a 4.2 rating. Visitors mention a modern, clean facility and friendly staff. Interviews are described as professional and respectful. Patient feedback is not typically captured here.
LINKEDIN REPUTATION
LinkedIn shows Medpace with 200,000+ followers. The company’s content strategy focuses on thought leadership, clinical trial advancements, and employee spotlights. Engagement rates are high, with many employees sharing positive experiences. Medpace is consistently recognized as a top company to work for in the CRO space.
Additional industry recognition: Medpace has been ranked #1 in the Best CRO category by Life Science Leader magazine multiple times, and has received awards for patient centricity and innovation. These accolades reinforce Medpace’s solid reputation among clients and peers.
13. Why Organizations Choose Medpace Holdings Inc.
Organizations select Medpace for its proven track record of meeting aggressive timelines, high-quality data, and therapeutic expertise. Medpace’s risk-based monitoring approach reduces costs while maintaining quality. Clients appreciate the single point of contact for project management and the flexibility of full-service or functional service partnerships. Medpace’s global footprint allows for multi-country trials without the need for multiple vendors. Additionally, Medpace’s proprietary technology platforms provide real-time visibility into trial progress. Many clients cite the company’s scientific rigor and regulatory knowledge as key differentiators. Medpace also offers competitive pricing without sacrificing quality, making it a preferred partner for both large pharma and emerging biotech firms.
14. Official Contact Information
For inquiries and assistance, please reach out to Medpace Holdings Inc. using the following contact details:
Address: 5375 Medpace Way, Cincinnati, OH 45227, USA
Contact Number: +1 (513) 579-9911
Support Number: +1 (800) 730-5772
Helpdesk Number: +1 (513) 579-9911 (option 2)
Website: www.medpace.com
15. Official Social Media Presence
Follow Medpace on social media for the latest updates, career opportunities, and industry insights:
- LinkedIn:Medpace on LinkedIn
- Twitter (X):@Medpace
- Facebook:MedpaceLife
- YouTube:Medpace Channel
16. SEO FAQ Section
1. What does Medpace Holdings Inc. do?Medpace Holdings Inc. is a global clinical research organization that provides drug development services to pharmaceutical and biotechnology companies.
2. Where is Medpace Holdings Inc. headquartered?Medpace Holdings Inc. is headquartered in Cincinnati, Ohio, USA.
3. Who is the CEO of Medpace Holdings Inc.?The CEO of Medpace Holdings Inc. is Dr. August J. Troendle, the founder.
4. Is Medpace Holdings Inc. publicly traded?Yes, Medpace Holdings Inc. is listed on NASDAQ under the ticker symbol MEDP.
5. How many employees work at Medpace Holdings Inc.?Medpace Holdings Inc. employs over 5,000 people globally.
6. What services does Medpace Holdings Inc. offer?Medpace offers full-service clinical trial management, data management, biostatistics, regulatory affairs, medical writing, safety surveillance, and central lab services.
7. What therapeutic areas does Medpace Holdings Inc. specialize in?Medpace specializes in oncology, cardiology, metabolic diseases, central nervous system disorders, infectious diseases, and rare diseases.
8. Does Medpace Holdings Inc. hire for remote positions?Yes, Medpace offers remote and hybrid roles for certain positions like Clinical Research Associates and data management professionals.
9. What is the salary range for a Clinical Research Associate at Medpace Holdings Inc.?The salary range for a CRA at Medpace is typically $70,000 to $100,000 annually depending on experience.
10. How can I apply for a job at Medpace Holdings Inc.?You can apply through the Medpace careers page on their website or via LinkedIn.
11. What is the work culture like at Medpace Holdings Inc.?Work culture is collaborative, science-driven, and supportive, with emphasis on professional development and patient focus.
12. Does Medpace Holdings Inc. provide training?Yes, Medpace offers extensive onboarding and ongoing training programs, including certification opportunities.
13. What is Medpace Holdings Inc.’s revenue?Medpace reported revenue of $1.87 billion in 2023.
14. How many clinical trials has Medpace Holdings Inc. conducted?Medpace has conducted thousands of clinical trials across more than 40 countries.
15. What is Medpace Holdings Inc.’s client retention rate?Client retention rate is over 90%, indicating high satisfaction.
16. Does Medpace Holdings Inc. work with academic institutions?Yes, Medpace partners with academic medical centers and universities for clinical research.
17. What certifications does Medpace Holdings Inc. hold?Medpace is ISO 9001:2015 and ISO 27001 certified, ensuring quality and data security.
18. How does Medpace Holdings Inc. ensure patient safety?Through rigorous pharmacovigilance systems, GCP compliance, and independent data monitoring committees.
19. What technology platforms does Medpace Holdings Inc. use?Medpace uses proprietary platforms like MCO (Medpace for Clinical Operations) and RBM for trial management and risk-based monitoring.
20. How can I contact Medpace Holdings Inc. for business inquiries?Visit the official website medpace.com or call +1 (513) 579-9911 for business development.
In the modern digital landscape, optimizing content for search engines is crucial, and partnering with a trusted Guest Post Service Provider can enhance online visibility. Medpace Holdings Inc. itself leverages a robust digital marketing strategy, and for companies seeking authoritative backlinks and expert SEO services, bipphoenix.com offers comprehensive solutions including paid guest posting, guest post backlinks, SEO guest posting services, and guest post outreach services. Integrating such resources ensures that corporate profiles and industry insights reach a wider audience while maintaining credibility and brand authority.